Generating health economics evidence to support cost-effective and value-based implementation of genomics and precision medicine. Melbourne Health Economics, The University of Melbournehttps://bsky.app/profile/eigen-uom.bsky.socialhttps://bsky.app/profile/eigen-uom.bsky.social/post/3mfiilltx6k2fOne of those weeks you don’t want to end! It was a pleasure to host our friends and collaborators from UBC. The visit provided a great opportunity to deepen our collaboration, exploring joint work in methodological development, cross-country analyses, and collaborative funding opportunities.23 Feb 2026 01:24 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3mfiilltx6k2fhttps://bsky.app/profile/eigen-uom.bsky.social/post/3mfiicnejr22fLast week, the Economics of Genomics & Precision Medicine Unit hosted an Aus–Canada workshop on optimising genomic medicine, with 40 participants from academia, clinicians, Cancer Australia, Genomics Australia, PBAC/MSAC, industry, and consumer advocates. Excited to pursue ideas & collaborations!23 Feb 2026 01:19 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3mfiicnejr22fhttps://bsky.app/profile/eigen-uom.bsky.social/post/3mf3ua6vmzk2fWhat is the value of genomic testing for Atrial Fibrillation? A new study led by Lizzy Liu and Ilias Goranitis found people highly value genomic testing for AF,at $2,900 for symptomatic patients and $2,600 for at risk relatives, with predicted uptake of 82% if publicly funded. go.unimelb.edu.au/xzr218 Feb 2026 00:48 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3mf3ua6vmzk2fhttps://bsky.app/profile/eigen-uom.bsky.social/post/3makhsrluuk2cNew publication 🎉 A systematic review of preferences for additional findings from genomic testing, led by Daniel Sheen with A/Prof Ilias Goranitis, is now published in the European Journal of Human Genetics. Read more: https://www.nature.com/articles/s41431-025-01968-w22 Dec 2025 05:10 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3makhsrluuk2chttps://bsky.app/profile/eigen-uom.bsky.social/post/3ma7sjcamzc27PhD opportunity in Health Economics: Quantifying the Value of Advanced Cell Therapy for Long-term Autoimmune Conditions: CAR-T Cell Therapy for Systemic Lupus Erythematosus. Led by the Uni of Manchester with a 12-month placement at UniMelb. More here: https://findanexpert.unimelb.edu.au/opportunity/1648-quantifying-the-value-of-advanced-cell-therapy-for-long-term-autoimmune-conditions--car-t-cell-therapy-for-systemic-lupus-erythematosus17 Dec 2025 23:22 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3ma7sjcamzc27https://bsky.app/profile/eigen-uom.bsky.social/post/3ma7rjd2e3k27PhD opportunity in Health Economics: Real world evaluation methods for health technology assessment of genomic technologies. Joint PhD based at the University of Melbourne with a minimum 12-month stay at the University of Manchester. More info here: https://findanexpert.unimelb.edu.au/opportunity/1647-real-world-evaluation-methods-for-health-technology-assessment-of-genomic-technologies17 Dec 2025 23:04 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3ma7rjd2e3k27https://bsky.app/profile/eigen-uom.bsky.social/post/3ma2vkyomk22nPhD opportunity in Health Economics: Evaluate the value, feasibility and sustainability of PERSONA, a precision prevention program for breast and ovarian cancer. Methods include early HTA, micro-costing and DCEs. More info here: https://findanexpert.unimelb.edu.au/opportunity/1638-economic-evaluation-of-a-breast-and-ovarian-cancer-precision-prevention-program-(persona)-for-unselected-young-women-from-the-general-population16 Dec 2025 00:33 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3ma2vkyomk22nhttps://bsky.app/profile/eigen-uom.bsky.social/post/3m7jmsptvus2tWe’re excited to welcome A/Prof Dean Regier as an Honorary within the EiGEN team. Dean is a leading international health economist at UBC and BC Cancer, with work spanning translational medicine, regulatory science, learning health systems and AI-supported real-world evidence in genomics.09 Dec 2025 03:41 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3m7jmsptvus2thttps://bsky.app/profile/eigen-uom.bsky.social/post/3m6nfi3zw6c25Determining the value of genomics in healthcare” is now published in Nature Medicine. Led by A/Prof Ilias Goranitis, the paper brings together international co-authors to examine how the value of genomics can be assessed. Read the full article: https://www.nature.com/articles/s41591-025-04061-327 Nov 2025 22:16 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3m6nfi3zw6c25https://bsky.app/profile/eigen-uom.bsky.social/post/3m2strj3jcc2pWhat a fantastic achievement! Congratulations to @zornitza.bsky.social, @iliasgoranitis.bsky.social and team on the publication of the BabyScreen+ genomic newborn screening study, out today in Nature Medicine. [contains quote post or other embedded content]10 Oct 2025 04:34 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3m2strj3jcc2phttps://bsky.app/profile/eigen-uom.bsky.social/post/3lytsipr45s2nLast week, Lizzy Liu and Mackenzie Bourke presented in an organised session at the AHES Conference in Canberra on the value of population-wide genomic risk assessment for cancer screening, alongside A/Prof Julia Steinberg from the Daffodil Centre.15 Sep 2025 02:53 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3lytsipr45s2nhttps://bsky.app/profile/eigen-uom.bsky.social/post/3lra6rsbgic2m📢 New publication in The European Journal of Health Economics! The paper assesses the psychometric performance CHU9D proxy version compared with the PedsQL in Australian children aged 0–7 years with congenital colorectal conditions. Read our findings: https://link.springer.com/article/10.1007/s10198-025-01797-0?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20250605&utm_content=10.1007%2Fs10198-025-01797-010 Jun 2025 05:44 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3lra6rsbgic2mhttps://bsky.app/profile/eigen-uom.bsky.social/post/3lqldxo3p7c2aRecently our team conducted two #DCEs as part of the BabyScreen+ program to elicit the Australian public’s preferences, values, and priorities for genomic newborn screening (gNBS) and its implementation. Read more here: https://sciencedirect.com/science/article/pii/S000292972500181801 Jun 2025 22:51 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3lqldxo3p7c2ahttps://bsky.app/profile/eigen-uom.bsky.social/post/3lop5ch32t223Excited to welcome Thuy Dung (“Dzung”) Nguyen as our new Research Assistant in the Economics of Genomics and Precision Medicine Unit! Dzung will be contributing to a project evaluating the cost-effectiveness of genomic testing for children/adults with suspected kidney disease.09 May 2025 00:12 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3lop5ch32t223https://bsky.app/profile/eigen-uom.bsky.social/post/3lmgr3tezo22zA few weeks ago, @iliasgoranitis.bsky.social presented at the Pan American Health Organisation webinar series. The webinar explored the challenges and opportunities of incorporating genomic innovations into health systems. https://youtube.com/watch?v=cPQrjrJld5E10 Apr 2025 05:21 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3lmgr3tezo22zhttps://bsky.app/profile/eigen-uom.bsky.social/post/3lluvc6obxc2m🔬 Excited to share our latest work: "The Cost Effectiveness of Genomic Medicine in Cancer Control", in collaboration with Cancer Australia and @who.int.03 Apr 2025 02:49 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3lluvc6obxc2mhttps://bsky.app/profile/eigen-uom.bsky.social/post/3llneo732kc23Preferences like testing uptake, treatment adherence, and trust in the healthcare system are key to evaluating genomic medicine. Ignoring them can bias cost-effectiveness and policy relevance. 🔎 Read the paper our team supported: rdcu.be/eaJBy31 Mar 2025 03:02 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3llneo732kc23https://bsky.app/profile/eigen-uom.bsky.social/post/3llne47fr4223How has publicly funded genetic and genomic tests been used in Australia? Read our recent study on test utilisation and MBS funding here: https://www.nature.com/articles/s41431-025-01801-431 Mar 2025 02:52 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3llne47fr4223https://bsky.app/profile/eigen-uom.bsky.social/post/3llftlf7vb22gOur team recently developed the Genomic Utility Valuation scale (#GUVscale), which systematically collects and weights key genomic outcomes to inform research, healthcare decision-making, and reimbursement priorities.28 Mar 2025 03:08 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3llftlf7vb22ghttps://bsky.app/profile/eigen-uom.bsky.social/post/3llftgdymlc2gCancer Australia recently launched the National Framework for Genomics in Cancer Control, a major step toward integrating genomics into routine cancer care for all Australians. Read the Framework: https://canceraustralia.gov.au/key-initiatives/national-framework-genomics-cancer-control28 Mar 2025 03:05 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3llftgdymlc2ghttps://bsky.app/profile/eigen-uom.bsky.social/post/3llctqnl2z223Our recent micro-costing paper found that proteomics offers a more cost-effective solution with broader applications compared to respiratory chain enzymology for mitochondrial disorders in Australia. Read more of our findings here: https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03462-w#Abs126 Mar 2025 22:33 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3llctqnl2z223https://bsky.app/profile/eigen-uom.bsky.social/post/3llctkubtns23Exciting research in #genomic_newborn_screening (gNBS)! Ilias and Riccarda contributed to this paper exploring public perspectives on which conditions should be included in #gNBS. Read more here: https://link.springer.com/article/10.1186/s40246-024-00611-x https://link.springer.com/article/10.1186/s40246-024-00611-x"26 Mar 2025 22:30 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3llctkubtns23https://bsky.app/profile/eigen-uom.bsky.social/post/3ll3ygazcds2kOur team, in collaboration with @ausgenomics.bsky.social, identified priority indicators for assessing the value of #genomic_testing in #rare_diseases, an important step toward standardising evidence generation. Read more here: pubmed.ncbi.nlm.nih.gov/38459833/ https://pubmed.ncbi.nlm.nih.gov/38459833/24 Mar 2025 05:08 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3ll3ygazcds2khttps://bsky.app/profile/eigen-uom.bsky.social/post/3ll3y5ic2i22kAn interesting paper from our team on #additional_findings in #genomic_sequencing. We report results from a #DCE exploring parental preferences for the process of returning additional findings and the value placed on this analysis for children with rare conditions. Read more here: rdcu.be/dyDkq https://rdcu.be/dyDkq24 Mar 2025 05:03 +0000at://did:plc:bfcmu7blcvvmft2n5k3jen4v/app.bsky.feed.post/3ll3y5ic2i22k